ID   CD166_RAT               Reviewed;         583 AA.
AC   O35112; O55172;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   24-JUL-2024, entry version 145.
DE   RecName: Full=CD166 antigen;
DE   AltName: Full=Activated leukocyte cell adhesion molecule;
DE   AltName: Full=HB2 {ECO:0000303|PubMed:9201982};
DE   AltName: Full=KG-CAM {ECO:0000303|PubMed:8004458};
DE   AltName: Full=Protein MEMD;
DE   AltName: Full=SB-10 antigen {ECO:0000303|PubMed:9556065};
DE   AltName: CD_antigen=CD166;
DE   Flags: Precursor;
GN   Name=Alcam;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=9201982; DOI=10.1074/jbc.272.27.16778;
RA   Matsumoto A., Mitchell A., Kurata H., Pyle L., Kondo K., Itakura H.,
RA   Fidge N.;
RT   "Cloning and characterization of HB2, a candidate high density lipoprotein
RT   receptor. Sequence homology with members of the immunoglobulin superfamily
RT   of membrane proteins.";
RL   J. Biol. Chem. 272:16778-16782(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 29-38.
RX   PubMed=8004458; DOI=10.1016/0006-8993(94)91885-6;
RA   Peduzzi J.D., Irwin M.H., Geisert E.E. Jr.;
RT   "Distribution and characteristics of a 90 kDa protein, KG-CAM, in the rat
RT   CNS.";
RL   Brain Res. 640:296-307(1994).
RN   [4]
RP   PROTEIN SEQUENCE OF 45-55; 58-71; 77-87; 111-129; 143-152; 154-160;
RP   176-189; 306-312 AND 406-423, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 94-156 AND 270-361.
RC   TISSUE=Mesenchymal cell;
RX   PubMed=9556065; DOI=10.1359/jbmr.1998.13.4.655;
RA   Bruder S.P., Ricalton N.S., Boynton R.E., Connolly T.J., Jaiswal N.,
RA   Zaia J., Barry F.P.;
RT   "Mesenchymal stem cell surface antigen SB-10 corresponds to activated
RT   leukocyte cell adhesion molecule and is involved in osteogenic
RT   differentiation.";
RL   J. Bone Miner. Res. 13:655-663(1998).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-167, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24090084; DOI=10.1021/pr400783j;
RA   Parker B.L., Thaysen-Andersen M., Solis N., Scott N.E., Larsen M.R.,
RA   Graham M.E., Packer N.H., Cordwell S.J.;
RT   "Site-specific glycan-peptide analysis for determination of N-glycoproteome
RT   heterogeneity.";
RL   J. Proteome Res. 12:5791-5800(2013).
CC   -!- FUNCTION: Cell adhesion molecule that mediates both heterotypic cell-
CC       cell contacts via its interaction with CD6, as well as homotypic cell-
CC       cell contacts. Promotes T-cell activation and proliferation via its
CC       interactions with CD6 (By similarity). Contributes to the formation and
CC       maturation of the immunological synapse via its interactions with CD6
CC       (By similarity). Mediates homotypic interactions with cells that
CC       express ALCAM. Mediates attachment of dendritic cells onto endothelial
CC       cells via homotypic interaction. Inhibits endothelial cell migration
CC       and promotes endothelial tube formation via homotypic interactions.
CC       Required for normal organization of the lymph vessel network. Required
CC       for normal hematopoietic stem cell engraftment in the bone marrow.
CC       Plays a role in hematopoiesis; required for normal numbers of
CC       hematopoietic stem cells in bone marrow. Promotes in vitro osteoblast
CC       proliferation and differentiation (By similarity). Promotes neurite
CC       extension, axon growth and axon guidance; axons grow preferentially on
CC       surfaces that contain ALCAM (By similarity). Mediates outgrowth and
CC       pathfinding for retinal ganglion cell axons (By similarity).
CC       {ECO:0000250|UniProtKB:P42292, ECO:0000250|UniProtKB:Q13740,
CC       ECO:0000250|UniProtKB:Q61490}.
CC   -!- SUBUNIT: Homodimer. Interacts (via extracellular domain) with CD6 (via
CC       extracellular domain). Homodimerization and interaction with CD6
CC       involve the same region and cannot occur simultaneously. The affinity
CC       for CD6 is much higher than the affinity for self-association.
CC       Interacts (via glycosylated extracellular domain) with LGALS1 and
CC       LGALS3. Interaction with LGALS1 or LGALS3 inhibits interaction with
CC       CD6. {ECO:0000250|UniProtKB:Q13740}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q61490};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:Q61490}.
CC       Cell projection, axon {ECO:0000250|UniProtKB:Q61490}. Cell projection,
CC       dendrite {ECO:0000250|UniProtKB:Q61490}. Note=Detected at the
CC       immunological synapse, i.e, at the contact zone between antigen-
CC       presenting dendritic cells and T-cells. Colocalizes with CD6 and the
CC       TCR/CD3 complex at the immunological synapse.
CC       {ECO:0000250|UniProtKB:Q13740}.
CC   -!- TISSUE SPECIFICITY: Strongest expression in the lung, then brain,
CC       liver, and kidney. Present in the somatosensory system, basal ganglia,
CC       cortex, olfactory system, and circumventricular organs.
CC   -!- DOMAIN: The CD6 binding site is located in the N-terminal Ig-like
CC       domain. {ECO:0000250|UniProtKB:Q13740}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- PTM: Glycosylated. {ECO:0000250|UniProtKB:Q13740}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB008538; BAA23279.1; -; mRNA.
DR   EMBL; BC061970; AAH61970.1; -; mRNA.
DR   EMBL; Y13240; CAA73692.1; -; mRNA.
DR   EMBL; Y13241; CAA73693.1; -; mRNA.
DR   RefSeq; NP_113941.1; NM_031753.1.
DR   AlphaFoldDB; O35112; -.
DR   SMR; O35112; -.
DR   STRING; 10116.ENSRNOP00000002738; -.
DR   GlyCosmos; O35112; 8 sites, 4 glycans.
DR   GlyGen; O35112; 8 sites, 4 N-linked glycans (3 sites).
DR   iPTMnet; O35112; -.
DR   PhosphoSitePlus; O35112; -.
DR   SwissPalm; O35112; -.
DR   PaxDb; 10116-ENSRNOP00000002738; -.
DR   GeneID; 79559; -.
DR   KEGG; rno:79559; -.
DR   UCSC; RGD:619972; rat.
DR   AGR; RGD:619972; -.
DR   CTD; 214; -.
DR   RGD; 619972; Alcam.
DR   VEuPathDB; HostDB:ENSRNOG00000001989; -.
DR   eggNOG; ENOG502RMQM; Eukaryota.
DR   HOGENOM; CLU_028888_2_0_1; -.
DR   InParanoid; O35112; -.
DR   OrthoDB; 5351031at2759; -.
DR   PhylomeDB; O35112; -.
DR   TreeFam; TF321859; -.
DR   PRO; PR:O35112; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000001989; Expressed in Ammon's horn and 20 other cell types or tissues.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0001772; C:immunological synapse; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0042101; C:T cell receptor complex; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0048846; P:axon extension involved in axon guidance; ISS:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; ISO:RGD.
DR   GO; GO:0007155; P:cell adhesion; ISS:UniProtKB.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; ISS:UniProtKB.
DR   GO; GO:0008045; P:motor neuron axon guidance; ISO:RGD.
DR   GO; GO:1990138; P:neuron projection extension; ISS:UniProtKB.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; ISS:UniProtKB.
DR   CDD; cd00096; Ig; 2.
DR   CDD; cd00098; IgC1; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 5.
DR   InterPro; IPR013162; CD80_C2-set.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR051116; Surface_Rcpt/Adhesion_Mol.
DR   PANTHER; PTHR11973:SF2; CD166 ANTIGEN; 1.
DR   PANTHER; PTHR11973; CELL SURFACE GLYCOPROTEIN MUC18-RELATED; 1.
DR   Pfam; PF08205; C2-set_2; 1.
DR   Pfam; PF13927; Ig_3; 1.
DR   SMART; SM00409; IG; 3.
DR   SUPFAM; SSF48726; Immunoglobulin; 4.
DR   PROSITE; PS50835; IG_LIKE; 4.
PE   1: Evidence at protein level;
KW   Adaptive immunity; Cell adhesion; Cell membrane; Cell projection;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Immunity;
KW   Immunoglobulin domain; Membrane; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000255"
FT   CHAIN           28..583
FT                   /note="CD166 antigen"
FT                   /id="PRO_0000014661"
FT   TOPO_DOM        28..527
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        528..549
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        550..583
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          28..120
FT                   /note="Ig-like V-type 1"
FT   DOMAIN          125..234
FT                   /note="Ig-like V-type 2"
FT   DOMAIN          245..328
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          333..409
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          416..501
FT                   /note="Ig-like C2-type 3"
FT   REGION          562..583
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        95
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        167
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PubMed:24090084"
FT   CARBOHYD        265
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        306
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        361
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        457
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        480
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        499
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        43..113
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        157..220
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        270..313
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        354..392
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        435..485
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   CONFLICT        339
FT                   /note="S -> G (in Ref. 5; CAA73693)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   583 AA;  65022 MW;  D36B73854F5DF61E CRC64;
     MASKGSPSCR LVFCLLISAA VLRPGLGWYT VNSAYGDTIV MPCRLDVPQN LMFGKWKYEK
     PDGSPVFIAF RSSTKKSVQY DDVPEYKDRL SLSENYTLSI NNAKISDEKR FVCMLVTEDN
     VFEAPTLVKV FKQPSKPEIV NRAAFLETEQ LKKLGDCISR DSYPDGNITW YRNGKVLQPV
     DGEVSILFKK EIDPGTQLYT MTSSLEYKTT KSDIQMPFTC SVTYYGPSGQ KTIYSEQAIF
     DIYYPTEQVT IQVLPPKNAI KEGDNITLQC LGNGNPPPEE FMFYLPGQAE GIRSSNTYTL
     TDVRRNATGD YKCSLIDQRN MAASTTITVH YLDLSLNPSG EVTKQIGDTL PVSCTISASR
     NATVVWMKDN IRLRSSPSFS SLHYQDAGNY VCETALQEVE GLKKRESLTL IVEGKPQIKM
     TKKTDPSGLS KTIICHVEGF PKPAIQWTIT GSGSVINQTE ESPYINGRYY SKIIISPEEN
     VTLTCTAENQ LERTVNSLNV SAISIPEHDE ADDISDENRE KVNDQAKLIV GIVVGLLLAA
     LVAGVVYWLY MKKSKTASKH VNKDLGNMEE NKKLEENNHK TEA
//
